poisar

Stocks · News reference

Lam Research shares are trading lower after a Form 4 filing showed its Chief Legal Officer sold 5,000 shares at an average price of $302.46 each. Also, UBS lowered its price target on the stock from $435 to $425.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Lam Research (LRCX) Rises Higher Than Market: Key Facts

    Lam Research (LRCX) closed at $292.66, up 1.51%, outperforming the S&P 500's 1.06% gain. The semiconductor equipment maker is expected to report strong earnings with EPS forecasted at $2.15 (up 70.63% YoY) and quarterly revenue of $8.1 billion (up 52.1% YoY). The stock holds a Zacks Rank #2 (Buy) rating with a Forward P/E of 30.91, trading at a discount to its industry average of 33.57.

    Read original at zacks-investment-research
  2. Zacks Investment ResearchNa

    PANW Q4 Earnings Beat Estimates on Platformization Strength

    Palo Alto Networks (PANW) reported Q4 fiscal 2026 revenues of $3.41B, up 34% YoY, beating consensus estimates. The company achieved record platformization with 220 net new platform additions (up 44%) and net new NGS ARR of $970M (up 98%). For fiscal 2027, PANW guides revenues of $14.10-$14.20B (23-24% growth) and NGS ARR of $11.075-$11.175B. Strong momentum across Network & AI Security, Cortex, and Idira platforms drove results.

    Read original at zacks-investment-research